Vicarious Surgical (RBOT) Revenue & Revenue Breakdown
Vicarious Surgical Revenue Highlights
00
Vicarious Surgical Revenue by Period
Vicarious Surgical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Vicarious Surgical generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Vicarious Surgical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $2.09M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Vicarious Surgical generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Vicarious Surgical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PIII | P3 Health Partners | $1.50B | $373.23M |
| QTTB | Q32 Bio | $1.16M | - |
| NXL | Nexalin | $168.72K | $18.15K |
| HYPD | Hyperion DeFi | $57.34K | $302.51K |
| ITRM | Iterum Therapeutics | - | $390.00K |
| BOLD | Boundless Bio | - | - |
| MODD | Modular Medical | - | - |
| INTS | Intensity Therapeutics | - | - |
| RBOT | Vicarious Surgical | - | - |
| PSTV | Plus Therapeutics | - | - |